PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Conscious Cogn. Author manuscript; available in PMC 2012 December 1.
Published in final edited form as:
PMCID: PMC3199289
NIHMSID: NIHMS328120

LOSS OF EMOTIONAL INSIGHT IN BEHAVIORAL VARIANT FRONTOTEMPORAL DEMENTIA OR “FRONTAL ANOSODIAPHORIA”

Mario F. Mendez, M.D., Ph.D. and Jill S. Shapira, R.N., Ph.D.

Abstract

Loss of insight is a prominent clinical manifestation of behavioral variant frontotemporal dementia (bvFTD), but its characteristics are poorly understood. Twelve bvFTD patients were compared with 12 Alzheimer's disease (AD) patients on a structured insight interview of cognitive insight (awareness of having a disorder) and emotional insight (concern over having a disorder). Compared to the AD patients, the bvFTD patients were less aware and less concerned about their disorder, and they had less appreciation of its effects on themselves and on others. After corrective feedback (“updating”), the bvFTD patients were just as aware of their disorder as the AD patients but remained unconcerned and unappreciative of its effects. These findings suggest that lack of insight in bvFTD is not due to “anosognosia,” or impaired cognitive and executive awareness of disease, but to “frontal anosodiaphoria,” or lack of emotional concern over having bvFTD and its impact on themselves and others.

Keywords: Insight, anosognosia, anosodiaphoria, dementia, frontotemporal dementia, Alzheimer's disease

1. INTRODUCTION

Loss of insight is characteristic of behavioral variant frontotemporal dementia (bvFTD). Consensus criteria for FTD include loss of insight as a core diagnostic feature of this disorder (Neary et al., 1998). These criteria defined loss of insight as a lack of awareness of mental symptoms which could be evidenced by either frank denial or unconcern for their consequences. Despite evidence that patients with bvFTD display a greater loss of insight into illness early in the dementia as compared to patients with Alzheimer's disease (AD) (Gustafson, 1993; Mendez & Shapira, 2005), recent studies suggest that loss of insight lacks specificity in dementia and does not effectively discriminate patients with these two conditions (Piquet, Hornberger, Shelley, Kipps, & Hodges, 2009). Moreover, some bvFTD patients may never experience impaired insight (Evers, Kilander, & Lindau, 2007), and this criterion has even been eliminated from the new, proposed International Criteria for bvFTD (Rascovsky et al., in press). It is likely that bvFTD is associated with a specific type of loss of insight not detected in some studies.

Loss of insight is common in dementia, the model of which is AD (Ott et al., 1996a; Ott, Noto, & Fogel, 1996b). Loss of insight occurs in up to 60% of patients with AD and correlates with severity and duration of illness (Mendez & Shapira, 2005; Migliorelli, Teson, Sabe, & Petracca, 1995). Loss of insight in AD also correlates with frontal dysfunction as evident by apathy, disinhibition, impaired mental flexibility, and other “frontal behaviors” and neuropsychological measures (Ansell & Bucks, 2006; Dalla Barba, Parlato, Lavarone, & Boller, 1995; Gallo, Chen, Wiseman, Schacter, & Budson, 2007; Hanyu et al., 2008; Kashiwa et al., 2005; Migliorelli et al., 1995; Michon, Deweer, Pillon, & Agid, 1994; Ott et al., 1996b; Reed, Jagust, & Coulter, 1993; Starkstein, Jorge, Mizrahi, & Robinson, 2006; Vasterling, Seltzer, & Watrous, 1997; Vogel, Hasselbalch, Gade, Ziebell, & Waldemar, 2005). In addition, studies searching for the neural correlates of insight in AD have indicated an association of recognition of one's illness with dysfunction of the frontal lobes, especially on the right, and the adjacent structures (Hanyu et al., 2008; Harwood et al., 2005; Ott et al., 1996b; Reed et al., 1993; Salmon et al., 2006, Shibata, Narumoto, Kitabayashi, Ushijima, & Fukui, 2008; Starkstein et al., 1995; Vogel et al., 2005).

Since loss of insight in AD involves the frontal lobes, this suggests that frontally-predominant dementias such as bvFTD may be particularly prone to impair insight (Mendez & Shapira, 2005). In fact, studies show greater loss of insight, particularly for personality traits, among patients with bvFTD compared to those with AD (Mendez & Shapira, 2005; Rankin, Baldwin, Pace-Savitsky, Kramer, & Miller, 2005; Salmon et al., 2008; Williamson et al., 2010). As compared to AD, where loss of awareness of memory and other cognitive deficits may predominate (Feher, Mahurin, Inbody, & Crook, 1994; Howorth & Saper, 2003, Ott et al., 1996a; Reed et al., 1993), in bvFTD, social and behavioral changes and personality traits may be particularly vulnerable to loss of insight (Eslinger et al., 2005; Rankin et al., 2005; Salmon et al., 2008). Patients with bvFTD tend to minimize negative behavioral changes, such as emotional detachment, and tend to exaggerate positive aspects of their behavior (Eslinger et al., 2005; Rankin et al., 2005; Zamboni, Grafman, Krueger, Knutson, & Huey, 2010). It appears that bvFTD may be particularly associated with a loss of the emotional and interpersonal aspects of insight.

Insight is a heterogeneous concept, and there may be specific mechanisms involved in loss of insight in bvFTD. Clinicians most frequently use “loss of insight” synonymously with loss of the ability to know or recognize one's own illness, or “anosognosia” (Babinski, 1914; Mograbi, Brown, & Morris, 2009; Starkstein et al., 2006). This term, originally referring to reduced awareness of hemiplegia in stroke patients due to parietal deficit in updating sensory-body representations, now applies to reduced awareness of any symptoms (Heilman, Barrett, & Adair, 1998; Spinazzola et al., 2008). Anosognosia for a disorder could result from inability to update information about the self, or a “petrified self” frozen in a time as proposed for AD (Hehman, German, & Klein, 2005; Mograbi et al., 2009; Morris & Hannesdottir, 2007). Anosognosia for a disorder could also result from inability to update awareness of the current self from lateral-frontal executive disturbances.

Among patients with bvFTD, who have more medial than frontal lobe involvement, this study proposes a different mechanism for loss of insight than anosognosia. As defined in the Consensus Criteria, “lack of insight” could be manifest, not only by lack of awareness, but also by lack of concern or “anosodiaphoria” (Mendez & Shapira, 2005). This term reflects a lack of emotional insight or concern over having a disorder or its potential impact on themselves and others. Among the bvFTD patients, we hypothesize that “updating” or corrective feedback can improve cognitive insight or awareness of disease, but updating does not improve emotional insight, or concern for their disorder.

This study uses a novel Structured Insight Interview to assess insight in patients with bvFTD. The limitations of patient questionnaires and of caregiver assessments pose problems for the assessment of insight (Clare, Marková, Verhey, & Kenny, 2005; Williams et al., 2010). Patients do not correctly see themselves or report their disorder or deficits, and caregivers are biased observers who indirectly report on the patients’ insight. Accordingly, this study devised the Structured Insight Interview approach in order to directly measure cognitive and emotional insight, response to updating, and the perceived impact of their illness among patients with bvFTD, compared to those with AD.

2. METHODS

2.1. Subjects

Twelve patients met the International Criteria for bvFTD (Rascovsky et al, 2011). These patients were recruited from the UCLA FTD&Neurobehavior Clinic, agreed to participate in a larger project on FTD or the UCLA Alzheimer's Disease Research Center, and gave informed consent. The criteria for a clinical diagnosis of probable bvFTD included progressive deterioration of behavior and/or cognition with three of the following: early behavioral disinhibition; apathy or inertia; loss of sympathy or empathy; perseverative, stereotyped or compulsive/ritualistic behavior; hyperorality and dietary changes; and deficits in executive tasks with relative sparing of episodic memory and visuospatial skills. These criteria were then supported by predominant frontal or anterior temporal hypometabolism on positron emission tomography imaging.

As a comparison group, 12 AD patients, age-matched for earlier age of onset, were recruited from the same program as a comparison group. These patients met criteria for clinically probable AD after an extensive evaluation involving clinical, neuropsychological, and neuroimaging. The severity of disease, and comparability of bvFTD and AD patients, was assessed using the Mini-Mental State Examination (MMSE) (Folstein, Folstein, & McHugh, 1975) and the Clinical Dementia Rating Scale (Morris, 1993), augmented with two additional items, a Behavioral Comportment and Personality Domain and a Language Domain, for the assessment of bvFTD patients (Knopman, Weintraub, & Pantratz, 2011).

2.2. Procedures

The bvFTD and AD patients underwent a Structured Insight Interview that probed knowledge of their disorder and their degree of concern (See Table 1). The interview consisted of three parts assessing awareness of the presence of a disorder (Part I); perception of decreased function from the disorder, or how it personally affects them (Part II); and perception of how their disorder affects others, particularly family and friends (Part III). Each of the three parts began with a lead question asking whether they were aware of having a disorder, its impact on themselves, or its impact on others. Following their response, regardless of whether they answered yes or no, the interviewer “updated” them with corrective feedback. Following each update or feedback statement, there were 12 yes-no questions, six assessed the patient's knowledge, or cognitive updating, and characterized by verbs such “know,” “understand,” “accept,” “think,” “believe,” or “agree,” and six other questions assessed concern, or emotional updating, and characterized by adjectives such as “concerned,” “worried,” “upset,” “disturbed,” “bothered,” or “anxious.” All questions were counterbalanced, both in cognitive and emotional updating and in the valence direction (positive or negative). Using the Structured Insight Interview, two clinicians in our program have shown inter-rater reliability (r=0.654) for 4 bvFTD and 4 AD patients.

TABLE 1
EXAMPLE OF STRUCTURED INSIGHT INTERVIEW & QUESTIONNAIRE

As part of their initial evaluation, the dementia groups underwent neuropsychological mental status tests based originally on the Consortium to Establish a Registry in AD (CERAD) and the Neurobehavioral Cognitive Status Examination (NCSE) (Kiernan, Mueller, Langston, & Van Dyke, 1987; Welsh et al., 1994). In addition to the MMSE, the assessment included digit span, verbal fluency for animals names, the 15-item mini-Boston Naming Test, an auditory comprehension score modified from the Western Aphasia Battery (Shewan & Kertesz, 1980), the Frontal Assessment Battery (FAB) (Dubois, Slachevsky, Litvan, & Pillon, 2000), a calculations test modified from the NCSE, and the CERAD verbal memory test rendering a savings score (Delayed Recall Learning/Learning Trial III) and a recognition score (accurate Yes answers on true-false recognition). Finally, the construction test evaluated copies of a circle, rhombus, overlapping rectangles, and a cube, for figure closure, 3-dimensionality, parallel opposite sides, correct internal lines, and frontal face orientation.

2.3. Data Analysis

Their responses were contrasted across groups on the Structured Insight Interview, including subscores for emotional and cognitive insight and for each of its three parts, and on the neuropsychological measures. The Structured Insight Interview results were further correlated with the variables from the neuropsychological items. The Structured Interview Questions yielded a Total Insight score with subscores for cognitive insignt, emotional insight and the three parts and their components. The subscore results are embedded post hoc scores, The individual correlations, however, were Bonferroni corrected for multiple comparisons.

3.0. RESULTS

There were no significant differences on basic demographic characteristics or most dementia severity measures (MMSE and standard CDR scores) between the two groups (See Table 2); however, the bvFTD patients had more impaired scores on the augmented CDR that included the additional domains of Behavioral Comportment and Personality (Knopman et al., 2011). On the neuropsychological measures, there were no group differences on most measures except, as expected, the bvFTD patients performed significantly better than the AD patients on the CERAD memory items and on constructions (See Table 3).

TABLE 2
Frontotemporal Dementia (bvFTD) versus Alzheimer's Disease (AD) Patient Characteristics
TABLE 3
Frontotemporal Dementia (bvFTD) versus Alzheimer's Disease (AD) Neuropsychological Characteristics

On the Structured Insight Interview, the bvFTD patients had worse Total Insight scores and emotional and cognitive insight subscores than the AD patients (See Table 4). Most bvFTD patients denied having a disorder or one with effects on themselves or others. The bvFTD patients differed significantly from the AD patients on the lead questions for presence of a disorder and for its effect on others. On Part I, after updated, there were no differences on cognitive awareness for presence of a disorder as most bvFTD and AD patients endorsed having a disorder. However, the bvFTD patients continued to show a relative lack of concern for the presence of their disorder. On Parts II and III, the bvFTD patients continued to show a lack of either cognitive awareness or emotional concern for the effects of having a disorder either on their own function and abilities or on their family and friends (See Table 4).

TABLE 4
FRONTOTEMPORAL DEMENTIA (bvFTD) versus ALZHEIMER'S DISEASE (AD) Structured Insight Interview

After correction for multiple comparisons, there was only one significant correlations between the scores and subscores of the structured Insight Interview and the neuropsychological measures (See Table 5). Part I, dealing with knowledge and concern for the presence of a disorder, correlated with better FAB scores, a measure of frontal-executive functions.

TABLE 5
CORRELATIONS BETWEEN INSIGHT INTERVIEW and NEUROPSYCHOLOGICAL MEASURES: Frontotemporal dementia and Alzheimer's disease patients

Finally, examples of patient responses to the Lead Questions were recorded. On the first Lead Question about having a disorder, bvFTD patients responded that “I have a dementia in my head, but I am getting rid of it,” and “I might have Alzheimer's disease.” For Lead Question II about the effects of the disorder on themselves, bvFTD patients responded: “It makes me lazy; I delay in responses and can’t focus on anything else besides one thing,” and “I cannot get a job.” For Lead Question III, bvFTD patients responded “Now I let my children mess with my life,” and “my wife is not happy because she is taking care of me.”

4.0. DISCUSSION

4.1. General discussion

Loss of insight among patients with bvFTD may be due to a lack of emotional insight. Compared to AD patients, those with bvFTD initially deny the presence of their disorder. After being informed that they do in fact have a disorder, bvFTD patients continue to experience decreased concern over their dementia despite similar awareness of their disease as the AD patients. Furthermore, the bvFTD patients do not appreciate the impact of their disorder on themselves or others as much as do the AD patients. These findings point to a loss of emotional insight from anosodiaphoria rather than from loss of cognitive awareness or anosognosia.

We do not have solid models for the mechanism of loss of insight in bvFTD. Insight among dementia patients does not correlate with cognitive impairments, such as in estimating personal attributes, e.g., their weight and eyesight, or in accurately characterizing others’ behavior (Banks & Weintraub, 2008; Ruby et al., 2007). A more common view is that the mechanism for loss of insight is anosognosia or inability to recognize one's own illness or deficits. Originally introduced by Babinski (1914) to refer to hemiplegic patients who ignore their paralysis, the term anosognosia has come to refer to lack or recognition of disease, disorder, symptoms, or dysfunction (Babinski, 1914; Heilman et al., 1998). Anosognosia could result from an inability to “update” awareness of having a disorder due to a loss of autobiographical memory and being “frozen” in outdated memories (Gallo et al., 2007; Hehman et al., 2005; Mograbi et al., 2009). Areas of the prefrontal cortex involved in bvFTD, especially on the right, may be activated when retrieving autobiographical memory (Cabeza & St Jacques, 2007; Gilboa, 2004; Keenan, Wheeler, Gallup, & Pascual-Leone, 2003). Anosognosia could also result from an inability to “update” awareness of having a disorder due to frontal-executive disturbances. In this “executive anosognosia” there may be an abnormal comparator or discrepancy detector for monitoring mismatches between relatively spared older memories and current performance (Abu-Akel, 2003; Hannesdottir & Morris, 2007; Mograbi et al., 2009; O'Keeffe et al., 2007). Executive anosognosia, however, may correspond to traditional lateral-frontal executive functions and cognitive awareness, which may not be the main cause of loss of insight in bvFTD.

Alternatively, loss of insight in bvFTD may result, not from a form of anosognosia, but from a loss of emotional insight or anosodiaphoria (Banks & Weintraub, 2009; Mendez & Shapira, 2005). Compared to the AD patients, the bvFTD patients are able to update awareness of their disorder at least to the level of the AD patients, but they remain more concerned and unable to update recognition of the effects of their disorder on themselves or on others. “Frontal anosodiaphoria” may represent a lack of concern for proper self-appraisal (Schmitz & Johnson, 2007; Williamson et al., 2010), and there is evidence that the ventromedial prefrontal cortex (VMPFC), especially on the right, and its adjacent connections are involved in this process (Kennan et al., 2003; Nakamura et al., 2001; Northoff, Heinzel, Bermpohl, Dobrowolny, & Panksepp, 2006; Stuss & Anderson, 2004; Van der Meer, Costafreda, Aleman, & David, 2010). The VMPFC and adjacent anterior cingulate and anterior insula, especially on the right, are the focus of disease in bvFTD (Amanzio et al., 2011; Bechara, 2004; Craig, 2009; Evers et al., 2007; Howorth & Saper, 2003; Mendez & Shapira, 2005; Thompson et al., 2005). Furhtermore, along with the anterior cingulate, the anterior insula participates in interoceptive and emotional awareness, sensations involved in self-appraisal and self-reflection (Critchley, Tang, Glaser, Butterworth, & Dolan, 2005; Gilboa et al., 2006; Schnyer et al., 2004; Singer, Critchley, & Preuschoff, 2009; Turner & Coltheart, 2010).

There are several methodological limitations of this study. First, insight can be difficult to assess in dementia without a caregiver or informant (Williamson et al., 2010). There are significant problems with clinician ratings (Clare et al., 2005), and patient interviews depend on whether the patient mentions cognitive problems without being prompted (Evers et al., 2007). This study used a novel Structured Insight Interview to try to get around these methodological issues and directly access the patients’ insight, as well as dissecting the different potential mechanisms involved. Second, despite the advantages of this instrument, it does not allow validity testing among normal subjects, since it depends on the presence of a disorder. On the other hand, the Yes-No questions have face validity for insight for disease, and the instrument has adequate inter-rater reliability. Third, there is the possibility that the cognitive or awareness questions were easier than the emotional or concern questions. This does not account, however, for an apparent differential benefit only for awareness of disorder and between the two groups. Finally, this preliminary study is suggestive but not conclusive of the underlying frontal mechanisms of anosodiaphoria in bvFTD. Nevertheless, it offers a clear direction for further exploration of insight in bvFTD and related disorders.

4.2. Conclusions

This study found that the loss of insight in FTD was more properly described as a “frontal anosodiaphoria” rather than as anosognosia (Mendez & Shapira, 2005). There is a lack of emotional updating or concern for having an illness; an absence of an emotional self-referent tagging of information on their disorder, possibly from disease in the VMPFC-anterior cingulate-anterior insula area, especially on the right. Investigators can build on this work and further clarify the underlying mechanisms responsible for loss of insight in brain disorders.

The Highlights of the article entitled: “Loss of Emotional Insight in Behavioral Variant Frontotemporal Dementia or “Frontal Anosodiaphoria.”

  1. Loss of insight results from bvFTD, a disorder affecting the medial frontal area.
  2. These patients have anosodiaphoria, or indifference, rather than anosognosia.
  3. This anosodiaphoria may result from a loss of emotional updating.
  4. Loss of emotional updating particularly impacts on self-referential processes.
  5. Frontal anosodiaphoria is a failure to emotionally tag self-referent information.

Acknowledgments

Funding/Support: This work was supported by grant #R01AG034499-02

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

REFERENCES

  • Abu-Akel A. A neurobiological mapping of theory of mind. Brain Res Rev. 2003;43:29–40. [PubMed]
  • Amanzio M, Torta DME, Sacco K, Cauda F, D'Agata F, Duca S, et al. Unawareness of deficits in Alzheimer's disease: role of the cingulate cortex. Brain. 2011;134:1061–1076. [PubMed]
  • Ansell EL, Bucks RS. Mnemonic anosognosia in Alzheimer's disease: A test of Agnew and Morris (1998). Neuropsychologia. 2006;44:1095–1102. [PubMed]
  • Babinski MJ. Contribution à l'etude des troubles mentaux dans l'hémiplégie organique cerebrale (Anosognosia) Revue Neurologique. 1914;22:845–848.
  • Banks S, Weintraub S. Self-awareness and self-monitoring of cognitive and behavioral deficits in behavioral variant frontotemporal dementia, primary progressive aphasia and probable Alzheimer's disease. Brain Cogn. 2006;67:58–68. [PMC free article] [PubMed]
  • Banks SJ, Weintraub S. Generalized and symptom-specific insight in behavioral variant frontotemporal dementia and primary progressive aphasia. J Neuropsychiatry Clin Neurosci. 2009;21:299–306. [PMC free article] [PubMed]
  • Bechara A. Disturbances of emotion regulation after focal brain lesions. Int Rev Neurobiol. 2004;62:159–193. [PubMed]
  • Cabeza R, St Jacques P. Functional neuroimaging of autobiographical memory. Trends Cogn Sci. 2007;11:219–227. [PubMed]
  • Clare L, Marková I, Verhey F, Kenny G. Awareness in dementia: A review of assessment methods and measures. Aging Ment Health. 2005;9:394–413. [PubMed]
  • Craig AD. How do you feel—now? The anterior insula and human awareness. Nat Rev Neurosci. 2009;10:59–70. [PubMed]
  • Critchley HD, Tang J, Glaser B, Butterworth R, Dolan J. Anterior cingulate activity during error and autonomic response. Neuroimage. 2005;27:885–895. [PubMed]
  • Dalla Barba G, Parlato V, Iavarone A, Boller F. Anosognosia, intrusions and ‘frontal’ functions in Alzheimer's disease and depression. Neuropsychologia. 1995;3:247–259. [PubMed]
  • Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology. 2000;55:1621–1626. [PubMed]
  • Eslinger PJ, Dennis K, Moore P, Antani S, Hauck R, Grossman M. Metacognitive deficits in frontotemporal dementia. J Neurol Neurosurg Psychiatry. 2005;76:1630–1635. [PMC free article] [PubMed]
  • Evers K, Kilander L, Lindau M. Insight in frontotemporal dementia: Conceptual analysis and empirical evaluation of the consensus criterion “loss of insight” in frontotemporal dementia. Brain Cogn. 2007;63:13–23. [PubMed]
  • Feher EP, Mahurin RK, Inbody SB, Crook TH. Anosognosia in Alzheimer's disease. Neuropsychiatry Neuropsychol Behav Neurol. 1991;4:136–146.
  • Folstein MF, Folstein SE, McHugh PR. “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res. 1976;12:189–198. [PubMed]
  • Gallo DA, Chen JM, Wiseman AL, Schacter DL, Budson AE. Retrieval monitoring and anosognosia in Alzheimer's disease. Neuropsychology. 2007;21:559–568. [PubMed]
  • Gilboa A, Alain C, Stuss DT, Melo B, Miller S, Moscovitch M. Mechanisms of spontaneous confabulations: a strategic retrieval account. Brain. 2006;129:399–414. [PubMed]
  • Gilboa A. Autobiographical and episodic memory – one and the same? Evidence from prefrontal activation in neuroimaging studies. Neuropsychologia. 2004;42:336–1349. [PubMed]
  • Gustafson L. Clinical picture of frontal lobe degeneration of non-Alzheimer type. Dementia. 1993;4:143–148. [PubMed]
  • Hannesdottir K, Morris RG. Primary and secondary anosognosia for memory impairment in patients with Alzheimer's disease. Cortex. 2007;43:1020–1030. [PubMed]
  • Hanyu H, Sato T, Akai T, Shimizu S, Hirao K, Kanetaka H, et al. Neuroanatomical correlates of unawareness of memory deficits in early Alzheimer's disease. Dement Geriatr Cogn Disord. 2008;25:347–353. [PubMed]
  • Harwood DG, Sultzer DL, Feil D, Monserratt L, Freedman E, Mandelkern MA. Frontal lobe hypometabolism and impaired insight in Alzheimer disease. Am J Geriatr Psychiatry. 2005;13:934–941. [PubMed]
  • Heilman KM, Barrett AM, Adair JC. Possible mechanisms of anosognosia: a defect in self-awareness. Philos Trans R Soc Lond B Biol Sci. 1998;353:1903–1909. [PMC free article] [PubMed]
  • Hehman JA, German TP, Klein SB. Impaired self-recognition from recent photographs in a case of late-stage Alzheimer's disease. Soc Cogn. 2005;23:118–123.
  • Howorth P, Saper J. The dimensions of insight in people with dementia. Aging Mental Health. 2003;7:113–122. [PubMed]
  • Kashiwa Y, Kitabayashi Y, Narumoto J, Nakamura K, Ueda H, Fukui K. Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits. Psychiatry Clin Neurosci. 2005;59:697–704. [PubMed]
  • Keenan JP, Wheeler MA, Gallup GG, Jr., Pascual-Leone A. Self-recognition and the right prefrontal cortex. Trends Cog Sci. 2000;4:338–344. [PubMed]
  • Kiernan RJ, Mueller J, Langston JW, Van Dyke C. The Neurobehavioral Cognitive Status Examination. A brief differentiated approach to cognitive assessment. Ann Int Med. 1987;107:481–485. [PubMed]
  • Knopman DS, Weintraub S, Pankratz VS. Language and behavior domains enhance the value of the clinical dementia rating scale. Alzheimer Dem. 2011;7:293–299. [PMC free article] [PubMed]
  • Mendez MF, Shapira JS. Loss of insight and functional neuroimaging in frontotemporal dementia. J Neuropsychiatry Clin Neurosci. 2005;17:413–416. [PubMed]
  • Michon A, Deweer B, Pillon B, Agid Y. Relation of anosognosia to frontal lobe dysfunction in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1994;57:805–809. [PMC free article] [PubMed]
  • Migliorelli R, Teson A, Sabe L, Petracca G. Anosognosia in Alzheimer's disease: A study of associated factors. J Neuropsychiatry Clin Neurosci. 1995;7:338–344. [PubMed]
  • Mograbi DC, Brown RG, Morris RG. Anosognosia in Alzheimer's disease – The petrified self. Consciousness Cogn. 2009;18:989–1003. [PubMed]
  • Morris JC. The Clinical Dementia Raging (CDR): current version and scoring rules. Neurology. 1993;43:2412–2414. [PubMed]
  • Nakamura K, Kawashima R, Sugiura M, Kato T, Nakamura A, Hatano K, et al. Neural substrates for recognition of familiar voices: A PET study. Neuropsychologia. 2001;39:1047–1054. [PubMed]
  • Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546–1554. [PubMed]
  • Northoff G, Heinzel A, Bermpohl GM, de F, Dobrowolny H, Panksepp J. Self-referential processing in our brain – A meta-analysis of imaging studies on the self. Neuroimage. 2006;31:440–457. [PubMed]
  • O'Keeffe FM, Murray B, Coen RF, Dockree PM, Bellgrove MA, Garavan H, et al. Loss of insight in frontotemporal dementia, corticobasal degeneration and progressive supranuclear palsy. Brain. 2007;130:753–764. [PubMed]
  • Ott BR, Lafleche G, Whelihan WM, Buongiorno GW, Albert MS, Fogel BS. Impaired awareness of deficits in Alzheimer disease. Alzheimer Dis Assoc Disord. 1996;10:68–76. [PubMed]
  • Ott BR, Noto RB, Fogel BS. Apathy and loss of insight in Alzheimer's disease: a SPECT imaging study. J Neuropsychiatry Clin Neurosci. 1996;8:41–46. [PubMed]
  • Piguet O, Hornberger M, Shelley BP, Kipps CM, Hodges JR. Sensitivity of current criteria for the diagnosis of behavioral variant frontotemporal dementia. Neurology. 2009;72:732–737. [PMC free article] [PubMed]
  • Rankin KP, Baldwin E, Pace-Savitsky C, Kramer JH, Miller BL. Self awareness and personality change in dementia. J Neurol Neurosurg Psychiatry. 2005;76:632–639. [PMC free article] [PubMed]
  • Rascovsky K, Hodges JR, Knopman DS, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of Revised Diagnostic Criteria for the Behavioral Variant of Frontotemporal Dementia. Brain. in press. [PMC free article] [PubMed]
  • Reed BR, Jagust WJ, Coulter L. Anosognosia in Alzheimer's disease: relationship to depression, cognitive function, and cerebral perfusion. J Clin Exp Neuropsychol. 1993;15:231–244. [PubMed]
  • Ruby P, Schmidt C, Hogge M, D'Argembeau A, Collette F, Salmon E. Social mind representation: where does it fail in frontotemporal dementia? J Cogn Neurosci. 2007;19:671–683. [PubMed]
  • Salmon E, Perani D, Herholz K, Marique P, Kalbe E, Holthoff V, et al. Neural correlates of anosognosia for cognitive impairment in Alzheimer's disease. Human Brain Mapping. 2006;27:588–597. [PubMed]
  • Salmon E, Perani D, Collette F, Feyers D, Kalbe E, Holthoff V, et al. A comparison of unawareness in frontotemporal dementia and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2008;79:176–179. [PubMed]
  • Schmitz TW, Johnson SC. Relevance to self: A brief review and framework of neural systems underlying appraisal. Neurosc Biobehav Rev. 2007;31:585–596. [PMC free article] [PubMed]
  • Schnyer DM, Verfaellie M, Alexander MP, LaFleche G, Nicholls L, Kaszniak AW. A role for right medial prefrontal cortex in accurate feeling-of-knowing judgments: evidence for patients with lesions to frontal cortex. Neuropsychologia. 2004;42:957–966. [PubMed]
  • Shewan CM, Kertesz A. Reliability and validity characteristics of the Western Aphasia Battery (WAB). J Speech Hear Disord. 1980;45:308–324. [PubMed]
  • Shibata K, Narumoto J, Kitabayashi Y, Ushijima Y, Fukui K. Correlation between anosognosia and regional cerebral blood flow in Alzheimer's disease. Neuroscience Letters. 2008;435:7–10. [PubMed]
  • Singer T, Critchley HD, Preuschoff K. A common role of insula in feelings, empathy and uncertainty. Trends Cogn Sci. 2009;13:334–340. [PubMed]
  • Spinazzola L, Pia L, Folegatti A, Marchetti C, Berti A. Modular structure of awareness for sensorimotor disorders: evidence form anosognosia for hemiplegia and anosognosia for hemianaesthesia. Neuropsychologia. 2008;46:915–926. [PubMed]
  • Starkstein SE, Jorge R, Mizrahi R, Robinson RG. A diagnostic formulation for anosognosia in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2006;77:719–725. [PMC free article] [PubMed]
  • Starkstein SE, Vazquez S, Migliorelli R, Teson A, Sabe L, Leiguarda R. A single-photon emission computed tomographic study of anosognosia in Alzheimer's disease. Arch Neurol. 1995;52:415–420. [PubMed]
  • Stuss DT, Anderson V. The frontal lobes and theory of mind: developmental concepts from adult focal lesion research. Brain Cogn. 2004;55:69–83. [PubMed]
  • Thompson JC, Stopford CL, Snowden JS, Neary D. Qualitative neuropsychological performance characteristics in frontotemporal dementia and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2005;76:920–927. [PMC free article] [PubMed]
  • Turner M, Coltheart M. Confabulation and delusion: a common monitoring framework. Cogn Neuropsychiatry. 2010;15:346–376. [PubMed]
  • Van der Meer L, Costafreda S, Aleman A, David AS. Self-reflection and the brain: a theoretical review and meta-analysis of neuroimaging studies with implications for schizophrenia. Neurosci Biobehav Rev. 2010;34:935–946. [PubMed]
  • Vasterling JJ, Seltzer B, Watrous WE. Longitudinal assessment of deficit unawareness in Alzheimer's disease. Neuropsychiatry Neuropsychol Behav Neurol. 1997;10:197–202. [PubMed]
  • Vogel A, Hasselbalch SG, Gade A, Ziebell M, Waldemar G. Cognitive and functional neuroimaging correlate for anosognosia in mild cognitive impairment and Alzheimer's disease. Int J Geriatr Psychiatry. 2005;20:238–246. [PubMed]
  • Welsh KA, Butters N, Mohs RC, Beekly D, Edland S, Fillenbaum G, et al. The Consortium to Establish a Registry in Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology. 1994;44:609–614. [PubMed]
  • Williamson C, Alcantar O, Rothlind J, Cahn-Weiner D, Miller BL, Rosen HJ. Standardised measurement of self-awareness deficits in FTD and AD. J Neurol Neurosurg Psychiatry. 2010;81:140–145. [PMC free article] [PubMed]
  • Zamboni G, Grafman J, Krueger F, Knutson KM, Huey ED. Anosognosia for behavioral disturbances in frontotemporal dementia and corticobasal syndrome: A voxel based morphometry study. Dementia Geriatric Cogn Disord. 2010;29:88–96. [PMC free article] [PubMed]